Rosetta Stone Keeps...
Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$44.40 0.50 | 1.14%
05/24/12 - 11:15 AM ET
838.86K / 2.15M
Vol / Avg. Vol:44.44 / 43.90
Open / Prev. Close:44.16 - 44.44
Today's Range:38.76 - 47.48
52 Wk Range:-3.81%
Performance YTD:TheStreet Rating:
Portfolios with GSK
- Portfolio NameUser Type
- Contributor10 Dividend Stocks Held by ...
- UserKAREL VON ZOETE
- UserMARIA DEL HUERTO
- ContributorHighest-Yielding Drug Stocks
- Contributor10 Stocks Owned by the Best...
- ProKen Fisher - Fisher Investm...
- Userethang
- User2012 performers
- UserW FRAZIER BRINLEY Portfolio 1
- User2012 WFB Favorite Portfolio
Latest GSK Headlines from TheStreet
- Bankia Customers Withdraw 1 Billion Euro: Hot Trends
05.17.12 | 12:05 pm - Bankia Customers Withdraw 1B Euros in One Week: Hot Trends 05.17.12 | 09:05 am
- Pfizer, Glaxo, J&J Grab ASCO Spotlight 05.16.12 | 06:05 pm
- Business Highlights 05.09.12 | 06:05 pm
- GlaxoSmithKline Takes Human Genome Bid Hostile: Hot Trends 05.09.12 | 10:05 am
- Glaxo's Bid for Human Genome Turns Hostile: Hot Trends 05.09.12 | 08:05 am
- 5 Things You Should Know Before the Stock Market Opens 05.09.12 | 06:05 am
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) 05.08.12 | 08:05 am
- Ex-Dividend Stocks: Boeing, Wal-Mart, Pfizer 05.08.12 | 06:05 am
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner 05.07.12 | 05:05 pm
Press Releases for GSK
- Stiefel Receives US FDA Approval Of Fabior⢠Foam, 0.1% - PR Newswire 05.11.12 | 07:05 pm
- FDA Approves Votrient® For Treatment Of Patients With Certain Types Of Advanced Soft Tissue Sarcoma - PR Newswire 04.26.12 | 06:04 pm
- Shionogi-ViiV Healthcare Announces Initial Data From Pivotal Phase III Study Of Dolutegravir In HIV - PR Newswire 04.02.12 | 02:04 am
- GlaxoSmithKline Invites Philadelphia Area And City Of Camden Healthcare Nonprofits To Apply For $40,000 IMPACT Awards - PR Newswire 03.06.12 | 01:03 pm
- Siemens Forms New Companion Diagnostics Partnerships With ViiV Healthcare And Tocagen - PR Newswire 02.07.12 | 11:02 am
- GSK Upbeat On Solid Results - Interviews With CEO And CFO - PR Newswire 02.07.12 | 07:02 am
- The New England Journal Of Medicine Publishes Study Showing LigoCyte's Norovirus Vaccine Demonstrates Protection Against Illness - PR Newswire 12.08.11 | 07:12 am
- Isis Selects Development Candidate, Isis-AATRx, To Treat AATD-Associated Liver Disease - PR Newswire 10.11.11 | 08:10 am
- Regulatory Update: GSK And XenoPort Submit Supplemental New Drug Application To FDA For Horizant™ In Postherpetic Neuralgia - Business Wire 08.09.11 | 04:08 pm
- GlaxoSmithKline Pledges $10 Million At White House Meeting On US Education Reform - PR Newswire 07.18.11 | 01:07 pm
Partner Headlines for GSK
- Lilly's GLP-1 Agonist Delivers - Analyst Blog - Zacks 05.23.12 | 07:05 pm
- Healthcare Biz Recap: GSK Shakes on Human Genome, Express Scripts Desires a Date Walgreen - Wall St. Cheat Sheet 05.23.12 | 11:05 am
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Glaxo Fails to Impress HGSI - Analyst Blog - Zacks 05.18.12 | 05:05 pm
- 4 New Reasons To Be Bullish On Sanofi Now - Seeking Alpha 05.13.12 | 09:05 am
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Ahead of Wall Street - May 9, 2012 - Ahead of Wall Street - Zacks 05.09.12 | 09:05 am
- Momentum Stocks On Warren Buffett's 10 High Dividend Stocks - Seeking Alpha 05.06.12 | 09:05 am
- This Developmental Pharma Has Potential To Be A Long Term Multibagger - Seeking Alpha 05.03.12 | 09:05 am
- Spectrum: Increased Fusilev Production May Boost Stock - Seeking Alpha 04.30.12 | 09:04 am
